Innate Pharma (IPHA) Assets Average (2018 - 2025)
Innate Pharma (IPHA) has disclosed Assets Average for 3 consecutive years, with $940.4 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Assets Average changed N/A year-over-year to $940.4 million, compared with a TTM value of $940.4 million through Dec 2024, changed N/A, and an annual FY2024 reading of $154.9 million, down 21.16% over the prior year.
- Assets Average was $940.4 million for Q4 2024 at Innate Pharma, up from $479.6 million in the prior quarter.
- Across five years, Assets Average topped out at $940.4 million in Q4 2024 and bottomed at $940.4 million in Q4 2024.